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1. Introduction 
Epidemiology involves the study of the frequency, distribution, and impact of diseases 
within a community in order to address potential prevention or treatment of these 
conditions. Accordingly, evaluating the epidemiology of coronary artery disease (CAD) 
constitutes a particularly wide spectrum that cannot be comprehensively covered in a 
solitary book chapter. Consequently this first section will provide an introductory broad 
overview of CAD including pathophysiological concepts, clinical manifestations, geographic 
variations and its impact on patient health. After defining the broader context of this large 
field, the specific scope of chapter will be outlined. 
1.1 Defining coronary artery disease 
The coronary circulation consists of coronary arteries, the microcirculation and the coronary 
veins. Its function is to supply oxygen and nutrients to the myocardium and remove carbon 
dioxide and waste products. The importance of this function is exemplified by the fact that a 
50% or more reduction in this blood supply to the myocardium is incompatible with life. 
Thus, not surprisingly, dysfunction of the coronary circulation may result in significant 
morbidity and mortality.  
Although beyond the scope of this chapter, it should be noted that disturbances of the 
coronary circulation may involve dysfunction within the microcirculation as well as the 
coronary arteries. Thus the all-encompassing term ‘coronary heart disease’ includes both CAD 
and microvascular dysfunction. The later may mimic the clinical manifestations of CAD and 
indeed may co-exist with CAD. However, defining the epidemiology of microvascular 
dysfunction is especially difficult since specialised investigations are required to confirm its 
presence, as it may occur in the absence of associated structural microvascular disease.  
In contrast, CAD is more readily identifiable and the most common underlying 
pathophysiological process is coronary atherosclerotic disease. This may be identified by 
imaging techniques such as coronary angiography, or unequivocally at post-mortem 
autopsy. Accordingly, detailing the epidemiology of CAD is more readily achievable and 
the focus of this chapter. 
1.2 Atherosclerotic coronary syndromes 
Coronary atherosclerotic disease involves the epicardial coronary arteries and may manifest 
as an acute or chronic coronary syndrome. Acute coronary syndromes (ACS) typically arise 
www.intechopen.com
Coronary Artery Disease 
 – Current Concepts in Epidemiology, Pathophysiology, Diagnostics and Treatment 
 
4 
from atherosclerotic plaque rupture with subsequent coronary thrombosis and/or spasm. 
The resulting coronary artery occlusion gives rise to intense myocardial ischaemia or even 
myocardial necrosis thereby manifesting as unstable angina or myocardial infarction. On 
occasions, the ischaemia/infarction may manifest as sudden cardiac death from malignant 
arrhythmias or acute pulmonary oedema in the compromised left ventricle. Hence ACS may 
have a spectrum of clinical manifestations ranging from unstable angina, acute myocardial 
infarction, acute pulmonary oedema or even sudden death, all arising from the same 
underlying pathophysiological process.  
Chronic coronary syndromes (CCS) may also arise from coronary atherosclerotic disease. 
This typically manifests as exertional angina arising from a coronary atherosclerotic lesion 
that has progressed to the extent that it compromises coronary blood flow to the 
myocardium during the increased oxygen demand associated with exercise. As this 
obstructive lesion is non-occlusive, adequate oxygen supply is restored once the excess 
myocardial oxygen demand is removed with the cessation of exercise and thus the 
resolution of the ischaemic chest pain. Hence the principal manifestation of CCS is angina 
pectoris, which can be monitored in epidemiologic studies. 
1.3 Geographic variations in coronary artery disease 
The global prevalence of these CAD-related clinical manifestations is increasing although 
there are regional variations that are influenced by the extent of economic development 
and social organisation. With industrialisation, there is a shift from nutritional and 
infectious disorders to the chronic diseases such as CAD. This ‘epidemiologic transition’ 
has been described as involving 4 stages (Omran, 1971), as detailed in Table 1, (Yusuf et 
al, 2001). In developing countries, infectious disease and nutritional deficiency are 
responsible for most deaths (Stage 1) and cardiovascular disease plays only a minor role. 
The cardiovascular disorders (CVD) that are prevalent in these communities include 
infectious disease such as rheumatic heart disease or nutritional disorders such as 
beriberi. With improvements in public health and nutrition, these conditions become less 
prevalent and disorders related to uncontrolled hypertension become more common 
(Stage 2). With further industrialisation, lifestyle diseases become more evident. Thus 
smoking, high fat diets and obesity result in the rapid development of atherosclerosis so 
that CAD mortality is a major cause of death in middle-aged individuals (Stage 3). With 
further improvements in public health measures to address these lifestyle risk factors and 
advances in medical care, atherosclerotic disease associated mortality is delayed so that it 
is a condition of the elderly (Stage 4). Progression through each of these transition stages 
is associated with a greater life expectancy. Moreover as shown in Table 1, cardiovascular 
disease (and especially CAD) contributes proportionally more to the total population 
mortality.  
As evident from Table 1, CAD is present across the globe although its frequency varies with 
geographic region. Consequently there is a wide spectrum in the prevalence of CAD in 
developing and industrialised countries; thus discussions relevant to one country may not 
be necessarily be pertinent to others. Hence it is important to report on the context of the 
findings when describing the epidemiology of CAD. 
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Transition Stage %Deaths* Cardiovascular Conditions Countries 
1. Infections & 
Nutritional 
Deficiency 
 
5-10% 
 Rheumatic Heart Disease 
 Nutritional Cardiomyopathy 
 Sub-Saharan Africa 
 Rural South America 
 Rural Southern Asia 
2. Hypertensive 
Diseases 
 
10-35% 
 Haemorrhagic Stroke 
 Hypertensive Heart Disease 
 China 
 Urban Southern Asia 
3. Atherosclerotic 
CVD in the 
Middle-aged 
 
35-65% 
 CAD 
 Atherothrombotic Stroke 
 Urban India 
 Latin America 
 Former USSR 
4. Atherosclerotic 
CVD in the 
Elderly 
 
< 50% 
 CAD 
 Atherothrombotic Stroke 
 Heart Failure 
 Western Europe 
 North America 
 Australia, New 
Zealand 
# Adapted from Yusuf et al, Circulation 2001, 104:2746-53. (Yusuf et al, 2001) 
*%Deaths from CVD, in relation to total deaths.   CVD = Cardiovascular Disease. 
Table 1. The Epidemiologic Transition of Cardiovascular Disease#. 
1.4 Health status in coronary artery disease 
Epidemiology not only involves monitoring diseases within the community but also their 
impact on health. Thus the focus should not only be on the disease manifestations of CAD 
(such as acute and chronic coronary syndromes) but also the patient’s perception of the 
impact of these disorders on their health. The term ‘health status’ (see Figure 1) is used to 
define the patient’s perception (rather than the clinician’s perception) of the disease process 
on their lifestyle. This incorporates the symptoms experienced (e.g. angina), the functional 
limitation from the symptom (eg reduced exercise tolerance) and quality of life (i.e. the  
 
Rumsfeld, Circulation 2002, 106:5-7. (Rumsfeld, 2002). Copyright gained from Wolters Kluwer Health 
04/08/2011 
Fig. 1. Summary of Patient-centred Health Status.  
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discrepancy between actual and desired function) (Rumsfeld, 2002). Thus congruous with 
our evolving patient-centred health care, this chapter will not only focus on CAD in relation 
to the prevalence and incidence of disease processes but will also detail the impact of CAD 
on health status. 
1.5 Scope of the chapter 
Considering the wide spectrum encompassing CAD epidemiology, it is necessary to limit 
the topics covered in this chapter. Thus the chapter will evaluate overall CAD mortality, 
myocardial infarction as an example of an ACS and chronic stable angina as the example of 
a CCS. Within each of these areas, the discussion will focus on (1) the difficulty and 
limitations in defining the condition and thus its impact in interpreting the data, (2) the 
prevalence of the condition, (3) the incidence of the condition, where relevant, (4) and the 
impact of the condition on health status, when appropriate. This comprehensive approach 
will provide a detailed evaluation of the epidemiology of CAD. 
Since the prevalence of CAD varies with geographic location, the discussion in this chapter 
will be largely focus on industrialised countries (i.e. Stage 4 countries, Table 1). Data from 
these countries are readily available, generally reliable and the prevalence of disease similar, 
although there are small differences even within these countries. Thus although the data 
presented in this chapter is comprehensive in relation to the industrialised countries, it is 
acknowledged that it is not globally inclusive. 
2. Coronary artery disease mortality 
2.1 Defining coronary artery disease mortality 
Detailing mortality data may seem straightforward since the presence/absence of death is 
seldom a contentious issue, however whether the death can be attributed or indeed is 
associated with CAD is more problematic. Many epidemiologic studies derive mortality 
data from administrative death registries. In most of these registries, the cause of death is 
obtained from the death certificate completed by the treating doctor, who ascribes the cause 
of death based upon clinical impression. This contrasts to the more objective assignment of a 
cause of death from formally conducted autopsy studies. Since non-forensic national 
autopsy rates are about 5% in most industrialised countries, the cause of death derived from 
these registries may be unreliable and this should be considered when interpreting the 
mortality data detailed below. 
2.2 Prevalence of coronary artery disease mortality 
CVD encompasses not only CAD but also cerebrovascular disease, peripheral arterial disease 
as well as other cardiac disorders, and is currently the leading cause of death in the world, 
particularly amongst women. The World Health Organisation (WHO) estimates that such 
diseases caused almost 32% of all deaths in women and 27% in men in 2004 (World Health 
Organisation [WHO], 2008).  CAD is the most common cause of CVD deaths (45% of all CVD 
deaths) accounting for 7.2 million deaths/year, or 12% of all deaths worldwide (Figure 2).  
In many developed countries, CAD is the single leading cause of death. In the United 
Kingdom (UK) in 2008, CAD was responsible for about one in five male deaths and one in 
eight female deaths; a total of 88,000 CAD deaths (15% of total deaths) (British Heart  
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*Source World Health Organisation, Global Burden of Disease 2004 Update 
Fig. 2. Distribution of Cardiovascular Diseases Accounting for Deaths Worldwide in 2004 
Foundation [BHF], 2010). Similarly in the United States in 2005, CAD was responsible for 
one of every five deaths, accounting for 445,687 deaths (18% of total deaths) (Lloyd-Jones et 
al, 2009). In Australia in 2006, CAD accounted for 22,983 deaths (17% of all deaths) and once 
more was the most common condition responsible for Australian deaths (Australian 
Institute of Health and Welfare [AIHW], 2010). 
2.3 Temporal changes in coronary artery disease mortality 
The ‘epidemiologic transition’ described above (Table 1), not only accounts for geographic 
variations in CAD but also temporal changes. Over the past 30 years, two epidemiological 
trends have been observed in relation to CAD mortality. In many developed countries there 
has been an initial rise followed by a fall, while in developing countries there has mainly 
been a rise in CAD mortality.  
In developed countries, there was a peak in CAD mortality in the 1950’s with a progressive 
decline since the 1960’s. The WHO Multinational MONItoring of trends and determinants in 
CArdiovascular disease (MONICA) project identified an annual 4% decline in CAD 
mortality rate trends over 10 years from the 1980’s across 21 countries (Tunstall-Pedoe et al, 
2000). For example, in 1996 Australia reported 29,637 deaths (23% of all deaths) due to CAD, 
and in 2006, the equivalent figure was 22, 983 (17% of all deaths).  This decline in CAD 
deaths rates over the past 2 decades has been the most remarkable in Denmark, Australia, 
Sweden, the Netherlands and Canada, with the rate of CAD death falling by more than 60% 
(Figure 3). These trends are consistent with an ‘epidemiologic transition’ from Stage 3 to 
Stage 4 in these countries and reflect an increased life expectancy with the onset of CAD 
manifestations at an older age. 
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Figure 3 also highlights the heterogeneity between the countries in the improved CAD 
mortality. Thus while many Western European countries have shown substantial 
improvements in CAD mortality as described above, the Eastern European countries (such 
as Hungary) generally showed less improvement. These trends typically parallel socio-
economic differences with the decline in CAD mortality being sharper in countries with a 
more favoured socio-economic status.   
In contrast, some developing countries have an increasing rate of CAD mortality. Indeed, 
the WHO estimates that 60% of the global burden of CAD occurs in developing countries. 
Although mortality estimates are difficult to obtain in some of these countries, broad 
assessments of overall CVD epidemiology report rising CVD mortality in urban China, 
Malaysia, Korea and Taiwan. In China, CVD mortality increased as a proportion of total 
deaths from 12.8% in 1957 to 35.8% in 1990 (Khor, 2001). Like many developing countries, 
it has experienced rapid urbanisation, socioeconomic and health changes, together with an 
increase in life expectancy - features consistent with stage 2 of the epidemiologic 
transition.  
2.4 Factors influencing coronary artery disease mortality 
The landmark Framingham Heart Study was established in 1948 by the US Public Health 
Service to investigate the epidemiology of atherosclerotic CVD and hypertension. Its 
contribution to this field was huge as it precipitated a paradigm shift in the approach to 
CVD. This study transformed the popular belief at the time, which regarded atherosclerotic 
coronary artery disease as a normal aging process, to the ground-breaking concept of ‘risk 
factors’ thereby proposing that lifestyle modification could prevent CVD. This iconic 
longitudinal study demonstrated that advancing age, smoking, hypercholesterolaemia, 
hypertension and obesity increased the risk of CVD. Subsequently, these investigators 
developed the ‘Framingham Risk Score’, which predicts the 10 year risk of developing CAD 
based upon age, cholesterol profile, blood pressure level, diabetic and smoking status. They 
conclude that at the age of 40 years, the lifetime risk of CAD is 50% for men and 33% for 
women. Further insights into CAD continue to evolve from the study including the role of 
gender, depression, and socioeconomic status. 
2.4.1 Age 
Ageing is an unmodifiable risk factor for CAD, with males clinically manifesting this 
condition at 50-65 years of age and females about 10 years later, following menopause 
(Lerner & Kannel, 1986). The WHO reports that the principal cause of death of people over 
65 years is CAD, and as age increases, a substantial proportion of deaths are among females. 
In many developed countries, the number and proportion of older people (i.e over 65 years) 
is increasing, which is largely explained by declines in fertility and mortality. The ageing 
population of many countries has accelerated the contribution of CAD to total disease 
burden. It is predicted that the global ageing population will maintain CAD as a 
predominant cause of death worldwide (Mensah, 2004).  
Among countries with high but declining CAD mortality, it is suggested that these trends 
are changing with respect to younger age subgroups (O'Flaherty et al, 2009). A slowing or 
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levelling of the decline in CAD mortality in young adults has now been reported in England 
and Wales, the US, France, Australia, and New Zealand. These findings are cause for 
concern, indicating that decades of progress in reducing deaths from CAD appear to be 
stalling. Changes in lifestyle factors in the young (increasing obesity and sedentary 
lifestyles) may account for this reduced improvement. 
 
*Source: Organisation for Economic Co-operation and Development (OECD), 2009. 
Notes: Mexico (1981, 2004), Italy, Portugal (1980, 2003). Uses ICD-9 codes 410-414 and ICD-10 codes I20-I25 
Source Organisation for Economic Co-operation and Development (OECD), 2009 
Fig. 3. Age Standardised CAD Death Rates in Developed Countries in 1980 and 2004 
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2.4.2 Gender 
CAD is the leading cause of mortality for both adult males and females alike worldwide.  
Although the initial manifestation of CAD is delayed in females by about ten years 
compared to males, there is not an abrupt increase in CAD mortality rates for females 
immediately following menopause but a progressive increase over subsequent years. Thus 
more elderly post-menopausal females succumb to CAD then men and have done so since 
1984 (Castelli, 1988). Nonetheless, CAD is not solely a disease of elderly women. 
In the US, among men aged 35 to 54, the average annual mortality rate from CAD fell by 
6.2% in the 1980’s, and levelled off between 2000 and 2002, with an annual decline of just 
0.5%. Among women in the same age group, the annual rate of death from CAD dropped by 
5.4% in the 1980’s.  Between 2000 and 2002, CAD mortality actually increased for females by 
an average of 1.5%. Furthermore, even in younger females (35 to 44 years), the CAD 
mortality increased by an average of 1.3% annually between 1997 and 2002. Overall within 
the transitional trends, the percentage decline in mortality rates has been far greater for men 
than women, particularly in the US, the UK, Australia and Sweden. The age-standardised 
mortality rate for males and females since 1978 for the UK is depicted in Figure 4. More 
alarming is the higher mortality rate observed for young females following myocardial 
infarction. Younger women, but not older women, have higher rates of death during 
hospitalisation for myocardial infarction than men of the same age (see Myocardial 
Infarction section below).  
 
Source British Heart Foundation, Coronary Heart Disease Statistics, 2010. 
Fig. 4. Age-standardised CAD Mortality in the United Kingdom for Males and Females from 
1978 to 2008 
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2.4.3 Geographic differences 
It is common to categorise CAD epidemiology by geographic region, however the natural 
history of CAD epidemics varies substantially between countries.  For example, in Europe, 
the changes in CAD mortality in France and Southern European countries were smaller than 
that observed in the UK and Finland. The differences in industrialised nations are clearly 
evident in Figure 3. In Asia, CAD mortality is similar in Hong Kong and China, but it is 
different to trends in Thailand and South Korea, which report lower CAD mortality rates.  
These differences may be attributed to a low prevalence of CVD risk factors in the South-
east Asian countries. Favourable trends observed in the US, Australia, Argentina, Chile and 
Cuba, who rates of CAD death are traditionally and substantially lower than in most other 
areas of the world, may in part be explained by improved control of hypertension, as well as 
better management of patients with CAD. In Eastern European countries, including 
Bulgaria, Croatia, Romania, and especially the Russian Federation, there is a persisting 
upward trend in mortality from CAD. Russian CAD mortality rates in the late 1990’s were 
higher than those of Finland, the USA, or Australia three decades earlier. 
Regional variation in Britain has been consistently reported for 25 years. In Scotland and 
Northern England, CAD death rates are the highest, Southern England the lowest and 
intermediate rates in Wales and Northern Ireland. The rate of sudden death for males in 
Scotland is 63% higher and for females it is 100% higher compared to the rates observed in 
South Western England. Furthermore, the highest mortality rates are concentrated in urban 
areas.  
2.4.4 Socio-economic status 
Socioeconomic status (SES) indicators, including education, income and occupation, are 
associated with CAD risk factors, morbidity, and mortality. Early studies beginning in the 
1930’s generally showed increased CAD prevalence with industrialisation and affluence in 
developed nations.  However, contemporary data demonstrate that low SES, i.e. less 
education, lower income, and blue-collar occupations are associated with increased rates of 
CAD and increased risk of CAD mortality. Correspondingly, lower SES groups also have 
the least favourable lifestyle characteristics, including obesity, smoking, high cholesterol, 
hypertension, and lack of physical activity.  It is suggested by some that these SES-related 
differences are increasing even as age-adjusted CAD mortality declines.   
The British Heart Foundation reports a clear gradient in CAD mortality across low to high 
SES group.  The inequality is more striking in females than males, with the CAD death rate 
being five times higher in female blue-collar workers compared to females in professional 
occupations. 
2.4.5 Depression 
Additional risk factors are continually being evaluated in order to identify their contribution 
to CAD mortality and thus potentially develop further targeted therapies. Research has 
consistently shown that depression is a risk factor contributing to both the development and 
complications of CAD.  Depressive symptoms, regardless of a formal clinical diagnosis have 
an unfavourable impact on mortality in CAD patients. Both major depression and elevated 
depressive symptoms are associated with at least a doubling in risk of subsequent death in 
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CAD patients. The negative prognostic effect also remains in the long-term and after 
adjustment for other risk factors. 
2.5 Summary comments 
Epidemiologic data on CAD mortality is limited by the data source since most are derived 
from administrative registries where the cause of death is obtained from subjectively 
completed medical certificates rather than objectively performed autopsies. Considering this 
limitation, CAD is reported as the world’s leading cause of mortality for men and women, 
being responsible for more than 7 million deaths each year. Although in developed nations 
CAD is the most common cause of death, globally over 60% of fatalities now occur in 
developing countries. It is clear that a wide spectrum in the prevalence of CAD mortality 
exits, and despite much effort to improve the disproportional mortality rates, a social 
gradient in CAD still remains. This is evident by the higher CAD death rates in lower SES 
areas within regions and even within countries, and also an apparent gender bias, 
particularly amongst younger women. With a slowing down of age-adjusted mortality, it is 
likely that social differences will increase. By 2030, it is projected that the number of CAD 
deaths will rise by up to 137% in developing nations, and by up to 48% in areas where CAD 
is in decline, as such CAD will remain the leading cause of death worldwide.  
3. Myocardial infarction 
3.1 Defining myocardial infarction 
Acute myocardial infarction (AMI) remains a leading cause of worldwide mortality, being 
responsible for 12.6% of total deaths each year (Beaglehole, 2004). As described above, AMI 
and unstable angina constitute the CAD-related acute coronary syndromes. AMI differs to 
unstable angina as the former is associated with evidence of myocardial necrosis. A variety 
of methods are available to detect myocardial necrosis including changes on the 
electrocardiograph (ECG), plasma cardiac markers (creatine kinase, troponin), imaging 
techniques (cardiac magnetic resonance imaging, myocardial scintigraphy) and ultimately 
autopsy gross pathology and histology. The availability of these techniques allow for the 
definitive diagnosis of AMI to be made. In contrast, the diagnosis of unstable angina is more 
subjective relying on clinical impression and the absence of evidence of myocardial necrosis. 
Accordingly, investigating unstable angina epidemiologic data is less reliable and so this 
chapter will focus upon AMI data only. 
The clinical diagnosis of AMI has evolved over the past 10-15 years with the need to make an 
early diagnosis so that prompt therapy can be instituted. Traditionally the diagnosis is made 
on the basis of chest pain symptoms, ECG changes and an abnormal plasma cardiac marker. 
These plasma cardiac markers are particularly pertinent as they are intracellular proteins that 
are released into the plasma when myocardial cell necrosis occurs. Previously the routine 
cardiac marker used was creatine kinase, which had limited sensitivity and specificity. The 
development of the more sensitive and specific troponin assay resulted in myocardial necrosis 
being detected in patients with a normal creatine kinase. When these troponin leaks were 
found to have prognostic implications, the clinical diagnosis of AMI was redefined to focus 
upon the troponin findings. Thus as shown on Table 2, a clinical diagnosis of AMI is primarily 
made on the basis of an abnormal troponin with at least one other feature; alternatively the 
diagnosis may be made on autopsy pathological examination (Thygesen et al, 2007). 
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This change in the diagnostic criteria for AMI, particularly with reference to the plasma cardiac 
marker, has resulted in more AMI’s being detected. Hence any longitudinal study of AMI will 
be confounded by the change in the criteria and needs to be considered when interpreting the 
epidemiologic data. This problem will be further compounded in the future with the evolution 
of high-sensitivity troponin assays, which may potentially detect even more AMI’s. 
In addition to detecting myocardial infarction in the acute setting, a number of the above 
techniques may detect a previous myocardial infarct. Thus epidemiological studies may 
survey a population to detect the frequency of myocardial infarction by techniques 
mentioned in Table 2 relating to ‘healed myocardial infarction’. Each of these methods has 
their advantages and disadvantages in relation to availability, cost and accuracy. These need 
to be considered when interpreting the epidemiologic data. 
Clinically, AMI has been sub-classified on the basis of the presenting electrocardiograph (ECG) 
as either ST-elevation myocardial infarction (STEMI) or Non-ST elevation myocardial 
infarction (NSTEMI). Differentiating these two forms of AMI is important as the immediate 
clinical management differs. In STEMI, immediate coronary reperfusion strategies (either 
percutaneous coronary interventions or thrombolysis) on arrival to hospital are mandated in 
order to reduce the risk of death. In contrast, NSTEMI does not require immediate intervention 
although early invasive therapy (at least within days) is preferred. This nomenclature has 
replaced the previous classification of Q-wave and non-Q wave myocardial infarction since the 
later ECG findings do not occur until late in the course of AMI evolution and do not influence 
contemporary management strategies. However, as mentioned above, the Q wave can be used 
to diagnose the presence of a previous myocardial infarct. 
 
Criteria for acute, evolving or recent Myocardial Infarction 
Either one of the following satisfies the diagnosis for acute, evolving or recent MI: 
1. Typical rise and/or fall in cardiac biomarkers (preferably troponin) with at least 
one of the following: 
 Ischaemia symptoms 
 Development of pathological Q waves in the ECG 
 Electrocardiographic changes indicative of ischaemia (ST-segment elevation 
or depression 
 Imaging evidence of new loss of viable myocardium or new regional wall 
motion abnormality. 
2. Pathologic findings of an acute myocardial infarction 
Criteria for healing or healed Myocardial Infarction 
Any one of the following criteria satisfies the diagnosis for healing or healed myocardial infarction:  
1. Development of new pathological Q waves with or without symptoms. Imaging 
evidence of a region of loss of viable myocardium that is thinned and fails to 
contract in the absence of a non-ischemic cause. 
2. Pathological findings of a healed or healing myocardial infarction. 
Adapted from Thygesen K et al. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525. 
Copyright permission gained from Oxford University Press 01/08/2011 
Table 2. Revised Definition of Myocardial Infarction  
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In the following sections, the prevalence and incidence of myocardial infarction are 
described. The prevalence of a condition refers to its frequency within a given population at a 
particular point in time. The incidence of a condition refers to the number of new cases 
within a given population over a specified period of time. The estimates detailed in these 
sections are derived from several data sources including hospital discharge data, general 
practice registries and patient self-report from national survey data. Accordingly, the 
reliability of the data is dependent on the data source. 
3.2 Prevalence of myocardial infarction 
Based upon self-reported myocardial infarction in a UK national survey, the prevalence of 
myocardial infarction was reported as approximately 4.1% of men and 1.7% of women in 
2006 (BHF, 2010). This represents some 1.5 million people within the UK. As shown in 
Figure 5, the prevalence is age-dependent, extending from 1% of men < 45 years of age to 
17% of those ≥ 75 years old. Furthermore, there is local geographic variation for all ages in 
the United Kingdom the highest prevalence is seen in men from Wales (9%) and women 
from Scotland (2.4%).  
Similarly, in the USA, the prevalence of myocardial infarction was 3.6% in 2006 based upon 
national survey data available from the American Heart Association (Lloyd-Jones et al, 
2009). The prevalence was slightly higher in African American males (5.1%) compared with 
Caucasian males (4.9%) but lower in African American (2.2%) females compared with their 
Caucasian counterparts (3%). As with the UK data, the prevalence of myocardial infarction 
was greater in the elderly compared with those < 50 years of age. 
In contrast to these developed countries, South Asian countries (such as India, Pakistan, 
Bangladesh, Sri Lanka, and Nepal) the highest prevalence of myocardial infarction is seen in 
those younger than 40 years of age, whereas it is less marked in those older than 60 years. 
These observations are consistent with Stage 3 of the epidemiologic shift (Table 1) and 
reflect the development of risk factors at younger ages (Joshi et al, 2007).  
3.3 Incidence of myocardial infarction 
While the prevalence of myocardial infarction reflects both previous and new (acute) 
myocardial infarcts, the incidence of myocardial infarction only reflects the later. The 
incidence of AMI has decreased in a number of developed countries during the past three 
decades, including the UK and remains the lowest in China and Japanese populations. Age 
adjusted data has indicated that for men and women between the ages of 35-64 years there 
are only 90/100,000 new cases for AMI in China and 20/100,000 new cases in Japan 
(Ueshima et al, 2008). 
The most recent estimates of incidence of AMI in the UK are based on national level data 
from associated hospital and/or mortality statistics and suggest that in Scotland the 
incidence of AMI has decreased by about 25% between 2000 and 2009 in both men and 
women. Thus considering all ages in Scotland in 2006, approximately 252/100,000 males 
were newly diagnosed MI cases and 118/100,000 females. 
In relation to the clinical type of AMI, it has been estimated that more than 3 million suffer 
from STEMI and 4 million people suffer from NSTEMI worldwide each year (White & Chew, 
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2008). The 6-month mortality rate following infarction has been reported as 4.8% for STEMI 
and 6.2% for NSTEMI in an international registry involving 14 countries (Goldberg et al, 2004). 
Other studies have also shown an adverse prognosis for NSTEMI compared with STEMI 
patients at 12 months post-infarction (Terkelsen et al, 2005; Montalescot et al, 2007). 
 
Adapted from the British Heart Foundation, 2010 report. Prevalence rates are weighted for non-
response. Respondents were asked to recall whether they had ever been diagnosed with myocardial 
infarction by a doctor.  
Fig. 5. Age specific prevalence of AMI in the United Kingdom, England, 2006  
3.4 Factors influencing myocardial infarction 
The prevalence and incidence of myocardial infarction can be influenced by demographic, 
biological and psychosocial factors, some of which are modifiable and thus potential 
therapeutic targets. These factors warrant further discussion. 
3.4.1 Demographic factors 
Acute myocardial infarction is rare in childhood and adolescent years but increases in 
prevalence in the middle decades, particularly in the developing countries. In developed 
countries it is increasingly becoming a disease of the elderly, which has important economic 
implications. For example, 70% of AMI admissions in Australia are for patient’s ≥ 65 years 
old. These patients often have a complicated course as they have existing co-morbidities that 
complicate the therapy of their AMI.  
Considerable interest has evolved in gender differences in CAD and is the focus of another 
chapter within this book. Epidemiologic data concerning AMI amongst women is now being 
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revised as early data primarily focused on middle-aged males. It is well described that men 
experience myocardial infarction about 10 years younger than women (Figure 5) but in the 
post-menopausal years, women rapidly catch up to the men. Despite this, women have a 
larger in-hospital mortality from their AMI until about the age of 80 years when they are 
similar to men (Figure 6) (Vaccarino et al, 1999). Of particular concern is that the greatest 
disparity in this mortality is between young women and men (Figure 6). The cause for this 
gender difference is not apparent and the focus of ongoing investigations. 
In addition to age and gender, geographic factors influence the incidence of AMI. These 
have been described above and are likely to be multifactorial in origin. Factors such as 
ethnicity, and following social economic class, industrialisation may all contribute to 
apparent geographic differences. 
 
Adapted from Vaccarino et al. NRMI. N Engl J Med. 1999; 341: 217-225.  
Fig. 6. Age & sex specific prevalence of AMI mortality   
3.4.2 Biological/lifestyle risk factors 
The Framingham Heart Study was instrumental in establishing modifiable biological risk 
factors that were associated with AMI. A plethora of subsequent therapeutic studies have 
since demonstrated that modifying these risk factors can prevent AMI thereby confirming 
the importance of these risk factors and establishing the practice of preventative cardiology. 
These risk factors have since been incorporated into many risk scores for predicting the risk 
of AMI. 
A potential limitation of the Framingham study is the select population studied; an east 
coast USA community. More recently a large multinational study has been conducted to 
evaluate the association between the conventional modifiable risk factors and AMI (Yusuf et 
al, 2004). The INTERHEART study recruited patients from 52 countries in a case-control 
study. They reported that the traditional risk factors described in the Framingham study 
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Smk = smoking, DM = diabetes mellitus, HTN = hypertension, Obes = obesity, PS = psychosocial, 
RFs = Risk Factors. Copyright Permission to use established from Elsevier 01/08/2011 
Fig. 7. Acute Myocardial Infarction Risk Factors. (Adapted from Yusuf et al, 2004) 
accounted for most of the risk of AMI, independent of the country (Yusuf et al, 2004). In 
particular, the risk of AMI increased with the following factors in descending order of their 
adjusted approximate odds ratio: dyslipidaemia (3.3-fold, as defined by apolipoprotein 
B/A1 ratio), smoking (2.9-fold), psychosocial factors (2.7-fold), diabetes (2.4-fold), 
hypertension (1.9-fold) and abdominal obesity (1.6-fold). Reduced exercise and daily 
fruit/vegetable intake also increased the risk. Figure 7 highlights the importance of these 
factors and in particular the exponential risks when these factors are combined.  
The prevalence of these biological factors within the community varies with age and gender, 
as shown in Figure 8. In relation to smoking rates, the UK prevalence is around 20% with 
the prevalence having peaked for men and even begun to decline; however for women they 
continue to climb. In contrast, hypercholesterolaemia, hypertension and diabetes all remain 
prevalent (Figure 8). Whereas the prevalence of hypertension and diabetes increases with 
age, the prevalence of hypercholesterolaemia plateau’s/declines in the elderly. 
3.4.3 Psychosocial factors 
Both social and psychological factors are associated with AMI risk. Socioeconomic factors 
such as shorter education and lower income (particularly in women), and unmarried 
cohabitation have been shown to contribute towards the risk of AMI (Nyboe et al, 1989). In 
particular, socioeconomic status, work and home roles may play an important prognostic 
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role, particularly in young women (Lacey & Walters, 2003). Women often work outside the 
home, in addition to their roles within the household as wives, mothers and caregivers to 
elderly parents. There is also mounting evidence that age, gender, and social class affect 
health related quality of life (HRQoL) in the general population, with women reporting a 
poorer HRQoL than men, particularly following a cardiac event. 
Depression is the leading cause of disability worldwide affecting more than 120 million 
people every year. It is known to be an independent risk factor for the onset and subsequent 
poor prognosis of CAD (Schrader et al, 2004; Schrader et al, 2006) and can be a precursor to 
AMI and even cardiac death. Following AMI, 65% of patients report experiencing symptoms 
of depression and major depression is present in 15-22% of these patients (Guck, 2001). 
Depressed patients, particularly women, are also at an increased risk of mortality, 
experience a greater likelihood of cardiac hospitalisation and suffer from poor HRQOL in 
the first year post AMI (Frasure-Smith et al, 1999). 
Depression has a significant, negative impact on psychological and social functioning, as 
well as on work and leisure-related activities. Patients who are depressed are more likely to 
experience social problems over the first year of post-MI recovery, are slower in returning to 
work, experience more frequent episodes of angina, report more physical impairment and 
are less likely to attend cardiac rehabilitation than are non-depressed patients (Carney and 
Freedland, 2003). 
3.5 Health status in myocardial infarction 
Mortality associated with myocardial infarction is well described and reflected in the CAD 
mortality figures described in section 2. However the impact on this disorder also must be 
considered in relation to health status. In a recent study, Maddox et al (Maddox et al, 2008) 
reported that almost 1 in 5 patients with AMI experienced ongoing angina 12 months 
following an infarct. The clinical determinants of this ongoing chest pain included cardiac 
variables such as a prior history of angina, post-infarct angina during the index hospital 
admission and previous coronary bypass surgery. Additionally, non-cardiac variables such 
as younger age, female gender, continued smoking post-infarction, and depression were 
also important. Indeed depression is not only associated with ongoing symptoms following 
AMI but is also an important determinant of subsequent HRQoL (Rumsfeld et al, 2001). 
3.6 Summary comments 
The diagnostic methods and criteria for AMI have evolved in recent years so that more 
infarcts can be detected with the current technologies. This needs to be considered when 
interpreting data (especially longitudinal data) concerning myocardial infarction. Despite 
this, it is clear that AMI is a leading cause of morbidity and mortality worldwide and is 
responsible for over 12% of deaths each year, with a larger majority of the population 
suffering from NSTEMI than STEMI. The incidence of AMI has decreased in the 
industrialised world due to lifestyle changes and therapeutics; however, rates are rising in 
developing countries such as Asia, Eastern Europe and parts of Latin America. Although the 
prevalence of AMI is higher in men of all age groups, it is concerning and unexplained why 
the in-hospital myocardial infarct mortality is higher in women, particularly in the 
premenopausal era. The factors influencing the occurrence of myocardial infarction have 
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been well addressed over the past 4-5 decades however the management of factors that 
influence health status in patients with a recent myocardial infarct require further 
development. 
 
Percentage of adults with blood cholesterol levels ≥ 5.0mmol/l. 
Fig. 8A. Prevalence of major biological risk factors by age and sex, in England in 2008.  
 
Hypertension - blood pressure > 140/80. 
Fig. 8B. Prevalence of major biological risk factors by age and sex, in England in 2008.  
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Diabetes mellitus – both Type I and II.   Source a, b & c - British Heart Foundation 2010 report. 
Fig. 8C. Prevalence of major biological risk factors by age and sex, in England in 2008.  
4. Chronic stable angina 
4.1 Defining chronic stable angina 
The evaluation of epidemiologic data concerning chronic stable angina is more challenging 
than assessing CAD mortality or myocardial infarction data. Unlike these other conditions, 
the diagnosis of chronic stable angina is largely based upon clinical criteria and can only be 
objectively assessed with specialised investigations such as invasive coronary angiography. 
As these techniques may not be performed in all individuals with chest pain or angina, the 
background frequency of the disease is difficult to quantitate. Accordingly, interpretation of 
data concerning chronic stable angina must be made in the context of the data collected, 
which may be merely on clinical impression in many studies. This limitation should be 
considered when reviewing this data. 
There exists a certain ambiguity in defining the term ‘angina pectoris’ which has arisen from 
its use to describe a group of clinical disorders rather than a symptom. First clinical 
characterised by William Heberden in his 1772 publication entitled ‘Some account of a 
disorder of the breast’(Heberden, 1772), it refers to a strangling sensation, which usually 
occurs on exertion, however patients may experience angina without physical activity 
whereupon it is referred to as rest angina (Maseri, 1995) .  
In contemporary medicine, ‘angina’ may be used in a more generic context, referring to any 
coronary heart disease syndrome that results in myocardial ischaemia. These angina 
syndromes may have different coronary pathophysiological mechanisms responsible for 
initiating the myocardial ischaemia, including coronary artery spasm and microvascular 
dysfunction. They may manifest as exertional or rest angina, depending upon the 
underlying mechanism. The clinical angina syndromes are summarised in Table 3 below.  
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Angina 
Syndrome 
Clinical Features 
Unstable Angina  Characterised by crescendo or rest angina 
 An acute coronary syndrome manifestation (may progress on to 
myocardial infarction) 
 Typically due to an unstable atherosclerotic plaque 
Stable Angina  Characterised by exertional angina 
 Typically due to a stable but tight obstructive coronary artery 
stenosis 
Prinzmetal 
Variant Angina 
 Characterised by rest or nocturnal angina 
 Typically due to coronary artery spasm 
Decubitus 
Angina 
 Characterised by angina when lying down 
 Typically due to left ventricular dysfunction resulting in 
redistribution of pulmonary fluids and thus increased cardiac 
workload. 
Silent Ischaemia  Absence of angina in the presence of documented ischaemia 
 May occur with coronary artery or microvascular dysfunction 
“Syndrome X”  Includes classical syndrome X, microvascular angina, coronary 
slow flow phenomenon 
 Characterised by prolonged episodes of exertional or rest angina 
 Typically due to coronary microvascular dysfunction 
Table 3. Types of Angina. Source British Heart Foundation, Coronary Heart Disease 
Statistics, 2010 
Despite these diverse implications for the term ‘angina’, it is most commonly used to refer to 
patients with chronic stable angina. Although the initial description of exertional angina by 
Heberden still holds true today, a more operational version has been detailed by the 
American College of Physicians (Diamond, 1983) . As summarised in Table 4, this definition 
describes angina as either ‘typical’ or ‘atypical’ on the basis of how many of the clinical 
features are consistent with exertional angina. In those patients with features of typical 
angina, the sensitivity and specificity for detecting significant coronary artery disease on 
angiography is respectively 91% and 87% in males, and correspondingly 89% and 63% in 
females (Detry et al, 1977). 
 
Chest Pain Features 
1. Substernal chest discomfort – characteristic quality (tightness) & duration (minutes) 
2. Provoking Factors – exertion or emotional stress 
3. Relieving Factors – rest or sublingual nitrates 
ACP Classification: Typical Angina – all 3 of above criteria met. 
   Atypical Angina – only 2 of above criteria 
   Non-cardiac Chest Pain – only 1 of above criteria 
Table 4. American College of Physicians (ACP) Angina Pectoris Definition 
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In this section, the data presented concerning ‘angina’ will predominantly focus on patients 
with chronic stable angina. It will concentrate on the prevalence, incidence, clinical profile, 
associated morbidity and mortality with this condition. Although the clinical features of the 
other forms of angina have been alluded to, their epidemiological aspects are less clearly 
described and unfortunately there are no studies that directly compare the prevalence or 
incidence of the various forms of angina. 
4.2 Prevalence of chronic stable angina 
Despite the declining incidence of myocardial infarction, the prevalence of angina remains 
high with direct costs in the United States in 2000 estimated at over $75 billion (Javitz et al, 
2004). Although the exact prevalence of stable angina is unclear, in the UK in 2009, it is 
estimated that 2.1 million people suffered from angina thus representing a prevalence of 
approximately 5% of men and 4% of women (BHF, 2010). Coronary heart disease accounts 
for 1 in 4 deaths in the UK and the lifetime risk for those over 40 years is 49% in men and 
32% in women.  
Similarly, in the United States, approximately 10.2 million Americans were reported to have 
angina in 2006 with 4.7% of Caucasian men and 4.5% of Caucasian women over the age of 
20 years affected (Lloyd-Jones et al, 2010). These data are primarily based upon patient self-
report of a history of angina and thus subject to limited validity.  
Although the prevalence of angina in the UK and USA are similar, it is affected by age, 
gender, ethnicity, and geographic region. As shown in (Figure 9), within the UK, the 
prevalence is almost 17% amongst males and 12% in females over the age of 75 years but is 
less than 1% of all those under 45 years of age. Furthermore for all ages, the prevalence of 
angina in men from Northern Ireland is approximately 6% whereas amongst Welshman it is 
4% (BHF, 2010). Ethnic differences in angina occurrence are well illustrated in the United 
States where the prevalence in men over the age of 20 years is 3.8% in Caucasians, 3.3% in 
African Americans, and 3.6% in the Hispanic population. The equivalent prevalence 
amongst females is 3.7%, 5.6% and 3.7%.  
4.3 Incidence of chronic stable angina 
Based upon surveying general practitioner patient case records, the incidence of newly 
diagnosed angina in the UK was estimated at 28,000 new cases in 2009 (BHF, 2010). Thus 
overall, approximately 49/100,000 males were newly diagnosed angina cases and 
28/100,000 females. Figure 10 illustrates the age-specific incidence of angina. 
4.4 Factors influencing chronic angina 
Several large prospective epidemiological studies have provided important insights into the 
characteristics of patients with chronic stable angina. One of these was the Coronary Artery 
Disease in gENeral practiCE (CADENCE) study (Beltrame et al, 2009), which recruited 2,031 
chronic stable angina patients from general practices across Australia. The sample was 
representative of this population based upon geographic location. It particularly focussed 
upon continuing angina symptoms in these patients and surprisingly found that almost 1 in 
3 continued to experience angina at least once a week, despite contemporary therapies. This  
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Source British Heart Foundation, Coronary Heart Disease Statistics, 2010 
Fig. 9. Age-specific Prevalence of Angina in the United Kingdom in 2009.   
 
Source British Heart Foundation, Coronary Heart Disease Statistics, 2010 
Fig. 10. Age-specific Incidence of Angina in the United Kingdom in 2009.  
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was similar to that reported in United States (Wiest et al, 2004) and in an international 
multicentre study (Kirwan et al, 2008). 
The clinical characteristics of the chronic stable angina population in the CADENCE study, 
is summarised in Table 5. As would expected, these are predominantly elderly males with 
many having conventional cardiovascular risk factors. Their angina symptoms were 
consistent with ACP defined angina in 72% of the patients. Most had experienced an 
episode of ACS at some stage of their chronic illness with almost half having experienced an 
acute myocardial infarction.   
Importantly, this study reported that gender or the presence of heart failure or peripheral 
arterial disease, were independent clinical determinants of ongoing weekly angina in 
patients with chronic stable angina (Beltrame et al, 2009). 
 
Clinical Characteristic Prevalence 
Coronary Artery Disease Risk Factors  
 Age 71 ± 11 years 
 Male gender 64% 
 Diabetes mellitus 30% 
 Hypertension 72% 
 Hypercholesterolaemia 78% 
 Previous or current smoker 59% 
 Obesity (BMI and/or waist circumference) 85% 
Associated Cardiovascular Disease  
 Previous acute coronary syndrome 70% 
 Cardiac Failure 22% 
 Peripheral Artery Disease 17% 
 Atrial Fibrillation 10% 
Angina Characteristics  
 Substernal chest discomfort 93% 
 Pain provoked by exertion 73% 
 Pain provoked by emotional stress 26% 
 Pain relieved by rest 54% 
 Pain relieved by sublingual nitrates 51% 
Table 5. Clinical Characteristics in Stable Angina Patients. Data from (Beltrame, Weekes et 
al. 2009). 
4.4.1 Gender 
In a gender sub-analysis of the CADENCE study, significant gender disparities in coronary 
risk factors, clinical features, diagnostic investigations and management were observed as well 
as differences in angina-related health outcomes (Dreyer et al, 2011). Although women had 
more frequent angina which was associated with greater physical impairment and a poorer 
quality of life, they were less extensively investigated, prescribed fewer cardio-protective 
agents, less likely to achieve guideline lipid or weight targets and were less likely to receive 
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any specialist cardiology review (Figure 11). The predilection for women having more 
frequent angina is likely to be multi-factorial and may include biological, clinical presentation 
and assessment differences between genders (Bairey Merz et al, 2006). For example, women 
may have smaller coronary arteries that are less amenable to revascularisation therapies. 
Furthermore, coronary microvascular dysfunction is more prevalent in women and angina 
resulting from this is less responsive to conventional anti-anginals. 
 
Fig. 11.  Gender comparisons in the clinical management of stable angina patients. Age 
adjusted frequency data for (a) cardiology review, (b) pharmacological therapy and (c) 
revascularisation therapy, in 2005 stable angina patients categorised by gender. (male vs. 
female: *p < 0.05,  **p < 0.01, ***p < 0.001). Data from Dreyer et al (2011). Copyright 
permission gained Elsevier 30/09/2011 
4.4.2 Co-morbidities 
As shown in Table 5, many chronic stable angina patients have a history of a previous MI 
and their cardiac prognosis will be influenced by this event. In chronic stable angina 
patients who have not previously experienced a myocardial infarct, the risk of myocardial 
infarct or all-cause death has been described as 1.7%/year and 1.9%/year, respectively 
(Lampe et al, 2000). 
Co-existing heart failure and/or peripheral arterial disease have been shown to be 
important determinants of on-going angina symptoms in patients with chronic stable angina 
(Beltrame et al, 2009). This potentially reflects the more extensive disease in these patients. 
Certainly, patients with chronic stable angina and co-existing peripheral arterial disease 
were more physically limited and a poorer quality of life than those without co-existing 
peripheral arterial disease (Wilson et al, 2011).  
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4.5 Impact of chronic stable angina on health status 
The CADENCE study not only demonstrated that many patients with chronic stable angina 
have frequent ongoing symptoms but also that frequent angina is associated with reduced 
physical limitations and a poorer quality of life (Beltrame et al, 2009). Although the 
CADENCE study utilised a threshold of angina of at least once week, the relationship is a 
continuum as shown in Figure 12. Thus the more frequent the angina, the greater the 
impairment in physical limitation and quality of life. Hence enquiring about angina 
frequency may provide useful clinical insights into the impact of the disorder on the 
patient’s quality of life. 
While enquiring about the frequency of angina provides some insights into the disability 
associated with the disorder, it does not replace a detailed history and evaluation 
identifying the full impact of the condition on the patient. Unfortunately clinicians may not 
be completely aware of the angina burden experienced by their patients as alluded to in the 
CADENCE study. In this study, the clinicians reported that 80% of their patients had 
optimally controlled angina and that 61% had minimal impairment in their physical activity 
by the angina. In contrast, patient questionnaires demonstrated that only 52% of patients 
reported being angina-free and only 47% described their angina as not limiting their 
enjoyment in life. Hence further efforts are required to bridge this gap between the patient’s 
experience and the clinician’s perception of the disability associated with angina. 
 
SAQ = Seattle Angina Questionnaire. Adapted from (Beltrame et al, 2009). Copyright gained 30/09/2011. 
Fig. 12. Relationship between Angina Frequency and Patient-assessed Quality of Life 
Indices. 
4.6 Summary comments 
Although data concerning the epidemiology of chronic stable angina must be interpreted 
with caution considering the objectivity of the data source, substantial information is 
available primarily based upon patient self-report and general practitioner clinic surveys. In 
developed countries, the estimated prevalence of stable angina is 4-5% and the incidence of 
new cases approximately 46/100,000 population. The chronic nature of this condition results 
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in significant impairment in patient health status with a recent study reporting that almost a 
third of patients have angina once a week. Since there is an inverse relationship between 
symptom frequency and its related physical limitation and quality of life, these patients 
have substantial health status impairment that warrants more attention. 
5. Key facts in the epidemiology of coronary artery disease 
Coronary artery disease (CAD) is the global leading cause of death and may manifest 
clinically as an acute coronary syndrome such as AMI, or a chronic coronary syndrome such 
as chronic stable angina. 
Concerning CAD Mortality: 
 It is estimated that 7.2 million people died world-wide in 2004 from CAD (i.e. 
approximately 12%of all deaths). 
 In developing countries the CAD mortality is rising but in developed countries it has 
been falling since the 1960’s. 
 CAD mortality varies with age, gender, geographic region, socioeconomic status and 
depression. 
Concerning Myocardial Infarction: 
 The prevalence of myocardial infarction within developed countries is approximately 3-
4%. 
 The incidence of new myocardial infarction within developed countries is 
approximately 200/100,000 population. 
 Factors influencing the frequency of myocardial infarction within the community 
include (a) demographic – age, gender, (b) lifestyle/biological – lipid profile, smoking 
status, blood pressure, diabetic status, obesity, fruit/vegetable intake, alcohol 
consumption, and (c) psychosocial factors. 
 Approximately 1 in 5 patients continue to experience angina 12 months following an 
AMI. The frequency of these ongoing symptoms is not only influenced by cardiac 
factors (such as a pre-infarction history of angina) but also non-cardiac factors such as 
age, gender and depression. 
Concerning Chronic Stable Angina: 
 The prevalence of chronic stable angina within developed countries is approximately 4-
5% 
 The incidence of newly diagnosed angina within developed countries is approximately 
46/100,000 population. 
 Factors that influence the frequency of angina symptoms in patients with chronic stable 
angina include female gender and co-existing heart failure or peripheral arterial 
disease. 
 Despite contemporary therapies in developed countries, almost 1 in 3 patients with 
chronic stable angina continue to experience angina at least once a week. Since angina 
frequency is inversely related to physical limitation and quality of life, these patients 
have a considerably impaired health status. 
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6. Appendix: definitions 
ANGINA PECTORIS – a strangling sensation in the chest resulting from myocardial 
ischaemia. 
CORONARY HEART DISEASE – a group of clinical disorders involving coronary circulatory 
dysfunction resulting in impaired coronary blood flow and thus myocardial ischaemia. This 
includes coronary atherosclerosis, coronary artery spasm and/or microvascular dysfunction.  
CRESCENDO ANGINA – angina pectoris that is occurring more frequently or with greater 
intensity, or with less provocation. It is a form of unstable angina. 
EXERTIONAL ANGINA – angina pectoris precipitated by exertion.   
INCIDENCE – the number of new episodes of a disorder over a period of time (eg new 
myocardial infarcts in 2007) 
MIXED PATTERN ANGINA – angina pectoris occurring during exertion but also on 
occasions at rest. 
MYOCARDIAL INFARCT – a pathological condition where inadequate coronary blood 
flow results in myocardial necrosis. 
MYOCARDIAL ISCHAEMIA – a pathological condition where an insufficient coronary 
blood flow results in inadequate oxygen supply and the accumulation of wastes products in 
the myocardium 
PREVALENCE – the number of patients with the disorder at any particular time (eg 
patients with a myocardial infarct in Britain). 
REST ANGINA – angina pectoris occurring at rest. 
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